PowerPoint プレゼンテーション
|
|
|
- うきえ いしなみ
- 5 years ago
- Views:
Transcription
1 ! ""! #$%"$!!!!!!! &'()(!*+!,-(.(/012! ')) /+123'()(/27)!
2 15
3 !
4 !! 89!
5 ! ')) /2EF/G'5H;:(E(C+)1)(:;<E>5IE<>>;B;G<);(2/').!
6 !!!!!!!!!!!!! $!
7 ! ')) /2EF/G'5H;:(E(C+)1)(:;<E>5IE<>>;B;G<);(2/').!
8 !
9 !
10 JKH! Viral genome Retroviral infection to germ cells Exogenous retroviruses entry Host genome Integration Ancestor Progeny ERV!
11 !!
12 L<:);2!7)!<E!M"NNNO!P/!H;:(E/!%84!#$$#Q#$$N!
13 ! &7<:>(2!R!K(':.<22!M#99#O!P/!H;:(E/!%S4!T89"QT89$!
14 ! &7<:>(2!R!K(':.<22!M#99#O!P/!H;:(E/!%S4!T89"QT89$!
15 ! U<2>72!R!U7>E(3QU<::;>(2!M#99$O!VDF<2G7>!;2!W()<2;G<E!K7>7<:G' $"4"ST"N8/!
16 ! 89! $! $!!
17
18 360my 230my icems
19 icems
20 ph5.5 SG1 SG2 SG3 ph7.5 Tight Junction Furuse and Tsukita et al., JCB 156: , 2002 Langerhans Cell Network Reviewed by Kubo, Nagao and Amagai, JCI 122: , 2012 icems
21 SG1 SASPase Human Mouse aa Protease TM 82% identity aa Protease TM? Human SASPase: Bernard et al., J. Invest. Dermatol Mouse SASPase: Matsui et al., J. Biol. Chem Mouse Taps: Rhiemeier et al., Am. J. Pathol (34kDa) (32kDa) SG1 +/- -/- Mouse Back Skin Epidermis SG1 icems Matsui et al., EMBO Mol. Med. 2011
22 ProfilaggrinSASPase SASP +/+ SASP -/- Cit Cit Cit? Keratin Filaggrin SASP SASP SASP SASP Profilaggrin Matsui et al., EMBO Mol. Med icems
23 360my 230my? icems
24 1 SASPase 2SASPase ( ) 3SASPase SASPase
25 ! Uterine ')) G/D;>G(F7:+'(>3;)<E/G(.572G+GE(37D;<5;.CX').5Y0ZQ#A/').!!!!
26 W<?7:!7)!<E/[!K73:(D1G);(2!M#99NO!"8A4!"NTQ#9N!
27 Nature(2000) 403: Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis SHA MI, XINHUA LEE, XIANG-PING LI, GEERTRUIDA M. VELDMAN, HEATHER FINNERTY, LISA RACIE, EDWARD LAVALLIE, XIANG-YANG TANG, PHILIPPE EDOUARD, STEVE HOWES, JAMES C. KEITH JR & JOHN M. MCCOY* Genetics Institute, Inc., 87 CambridgePark Drive, Cambridge, Massachusetts 02140, USA * Present address: Biogen Inc., 14 Cambridge Center, Cambridge, Massachusetts 02142, USA
28 Nature(2000) 403:
29 Nature(2000) 403:
30 !!!!! %9!!A9\!!
31 !! Binucleate cells Mononucleate cells!!
32 !!
33 !!
34 !!
35 W(F;27!72D(C72(1>!:7):(F;:1>!]WJKHQ]! BERV-K1 BERV-K2 ^-K! gag pol %&'$ ^-K! ^-K! gag!"#$ %&'$ ^-K! pro pro SP SU TM SP SU TM -2 Hydrophobicity Hydrophobicity Amino acid sequence Amino acid sequence env2erv W<*<!7)!<E/!M#9""O!AT4"#8%Q"#$T!
36 J2F! beta BERV-K1 BERV-K2 enjsrv delta alpha gamma lenti BERV-Ks W<*<!7)!<E/!M#9""O!AT4"#8%Q"#$T!
37 WJKHQ]!%&'!.KZV>! BERV-K1 BERV-K relative expression levels (BERV-K1/GAPDH) Pl Lu Li Sp He Mu Ki Sk Te EM relative expression levels (BERV-K2/GAPDH) Pl Lu Li Sp He Mu Ki Sk Te EM W<*<!7)!<E/!M#9""O!AT4"#8%Q"#$T!
![WJKHQ]!%&'$ %&'$ 3_YT5W]J2F`^VY^-K! ^-K!](/docs-images/91/105099700/images/38-0.jpg "(kda) 80 60 Empty K1 K2 &:7G1:>(:! 50 40 _&!")
38 WJKHQ]!%&'$ %&'$ 3_YT5W]J2F`^VY^-K! ^-K! (kda) Empty K1 K2 &:7G1:>(:! _&! cleavage _a! TM Cos-7 cells cleavage FLAG !!!!!!!!!!!!!!!!!!!!!!!!!!!-L! -FLAG -Tubulin Env TM EnvK1
![WJKHQ]!J2F!](/docs-images/91/105099700/images/39-0.jpg "Env Fusion")
39 WJKHQ]!J2F! Env Fusion Cos7/GFP/Env Cos7/DsRed Empty BERV-K1 BERV-K2 VSV-G BERV-K1 Env
40 WJKHQ]!J2F! Fusion ^1G! Cos-7/Env (effector cells) Relative luciferase activities Cos-7 cells Target cells Empty K1 K2 VSV-G Relative luciferase activities ^1G! Bovine endometrial cells Empty K1 K2 VSV-G BERV-K1 Env
41 ! BERV-K1 Env BERV-K1 Env
42 WJKHQ]"!
43 !
![! WJKHQ]"!](/docs-images/91/105099700/images/44-0.jpg "(%)*+$")
44 ! WJKHQ]"! (%)*+$ (%)**,-.#*$ /0&10.2&34$ /0&10.2&35$ _+2G+);2!"! _+2G+);2!#!!
45 !!
46 8! UbHQ"! UbHQ#! _bh VYL! bbb! H;>2<! `bh! KJ^b]! JbVH!!!! UJKHQ^! cd_h! U`H! ``H! K_H! LL-H! L&LH! P_KH!! bb! cjuhq"! cjuhq#! W^H!!! UJKHQK! L1^H! `7^H! Y<^H! UJKHQc! &JKH! ](KH! U-^HQ#! U-^HQ"!! b!
47 !! SINE T[999! LINE 30
48 !! ](KH! "#$! YV^H! "#$! 678$19:"#2!JKH!!!!!!! "#$! "#$!!
49 d76<22;7e!7)!<e/!h;:<e!_<b7)+!r!je):<27(1>!vc72)>!-7>);2c!b(:!h7)7:;2<:+!h<gg;27>!m#9"9o!!!!
50 ! Q"[!8!Y-!]f!3;C! &JKH!
51 Vaccines A B C D E F G H I RT-PCR (env) d;:7g)! Real time RT-PCR (Copy number/ml) 4.5 x x x10 6 BGL BGL 1.0 x10 6 BGL 2.1 x x10 8 LacZ MR assay f2!g7ee>! PCR TCID 50 (/shot) 1,800 1, ND** ND ND ND 10,000! 180 *BGL: Background level; **ND: not detected; ***NT: not tested L;+<?<6<!7)!<E/!;$<2:"#=!M#9"9O[!0(>';@<6<!7)!<E/!52"#")219#8!M#9"#O!!
52 KdQ""$ KdQ""$!F;:1>!;2B7G)>!D(C>! PCR (env) "T9 #9"9O!
53 ! gg!
54 !
55 ! #!!!!., Vol. 26, pp (2010).
56 !!! MIK&O!! $!M_;.;<2!:7):(F;:1>!)+37!$4!_KH$O!!
57
58 _KH$M"/A"9 S -Ibd T9 5.EO M"T.EOMT.E!
59 !!MO!
60 !MO!
61 ! _KH$!!!! _KH$!! _KH$!
62 !! _KH!!
63 KdQ""$hM`GJHi_KHO#! )9)3!"#! %&'! L^H! _KH! _KH!!!! KdQ""$!
64 !!!!!j!!! j!!!!!!!!!!!!!!!
65 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
66 ! 3 2 1! )<@<F7)kC((/=3!
67 ! #9"#%"#!
一般演題（ポスター）
6 5 13 : 00 14 : 00 A μ 13 : 00 14 : 00 A β β β 13 : 00 14 : 00 A 13 : 00 14 : 00 A 13 : 00 14 : 00 A β 13 : 00 14 : 00 A β 13 : 00 14 : 00 A 13 : 00 14 : 00 A β 13 : 00 14 : 00 A 13 : 00 14 : 00 A
日本糖尿病学会誌第58巻第1号
α β β β β β β α α β α β α l l α l μ l β l α β β Wfs1 β β l l l l μ l l μ μ l μ l Δ l μ μ l μ l l ll l l l l l l l l μ l l l l μ μ l l l l μ l l l l l l l l l l μ l l l μ l μ l l l l l l l l l μ l l l l
日本糖尿病学会誌第58巻第3号
l l μ l l l l l μ l l l l μ l l l l μ l l l l l l l l l l l l l μ l l l l μ Δ l l l μ Δ μ l l l l μ l l μ l l l l l l l l μ l l l l l μ l l l l l l l l μ l μ l l l l l l l l l l l l μ l l l l β l l l μ
日本糖尿病学会誌第58巻第2号
β γ Δ Δ β β β l l l l μ l l μ l l l l α l l l ω l Δ l l Δ Δ l l l l l l l l l l l l l l α α α α l l l l l l l l l l l μ l l μ l μ l l μ l l μ l l l μ l l l l l l l μ l β l l μ l l l l α l l μ l l
第89回日本感染症学会学術講演会後抄録（I）
! ! ! β !!!!!!!!!!! !!! !!! μ! μ! !!! β! β !! β! β β μ! μ! μ! μ! β β β β β β μ! μ! μ!! β ! β ! ! β β ! !! ! !!! ! ! ! β! !!!!! !! !!!!!!!!! μ! β !!!! β β! !!!!!!!!! !! β β β β β β β β !!
表1.eps
Vol.1 C ontents 1 2 cell-free EMBO J Proc. Natl. Acad. Sci. USA NatureEMBO J 3 RNA NatureEMBO J Nature EMBO J 4 5 HCV HCV HCV HCV RNA HCV in situ 6 7 8 Nat Struct Mol Biol J Biol Chem Nat Commun J Virol
ｒｏｎ０４－０２／ｋｙ７６８４５０３１６８０００３５９４６
β α β α β β β α α α Bugula neritina α β β β γ γ γ γ β β γ β β β β γ β β β β β β β β! ! β β β β μ β μ β β β! β β β β β μ! μ! μ! β β α!! β γ β β β β!! β β β β β β! β! β β β!! β β β β β β β β β β β β!
第86回日本感染症学会総会学術集会後抄録（II）
χ μ μ μ μ β β μ μ μ μ β μ μ μ β β β α β β β λ Ι β μ μ β Δ Δ Δ Δ Δ μ μ α φ φ φ α γ φ φ γ φ φ γ γδ φ γδ γ φ φ φ φ φ φ φ φ φ φ φ φ φ α γ γ γ α α α α α γ γ γ γ γ γ γ α γ α γ γ μ μ κ κ α α α β α
Various function and toxicity of iron Key words 1) Hentze, M. W. et al: Cell, 117, 285-297 (2004) 2) Ganz, T.: Blood, 102, 783-788 (2003) 3) Nemeth, E. et al.: Science, 306, 2090-2093 (2004) 4) Hentze,
診療ガイドライン外来編２０１４（Ａ４）／ＦＵＪＧＧ２０１４‐０１（大扉）
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
物理化学I-第12回(13).ppt
I- 12-1 11 11.1 2Mg(s) + O 2 (g) 2MgO(s) [Mg 2+ O 2 ] Zn(s) + Cu 2+ (aq) Zn 2+ (aq) + Cu(s) - 2Mg(s) 2Mg 2+ (s) + 4e +) O 2 (g) + 4e 2O 2 (s) 2Mg(s) + O 2 (g) 2MgO(s) Zn(s) Zn 2+ (aq) + 2e +) Cu 2+ (aq)
研究成果報告書
Functional analysis on EphB and ephrin-b expressing in gastric mucosaand their expression behavior in gastric ulcer and cancer EphBephrin-B EphBephrin-Bephrin-BEphB Gastric UnitEphB2 EphBephrin-BEphB/ephrin-B
表紙４＿１／山道 小川内 小川内 芦塚
1 2008.1Vol.23 2008.1Vol.23 2 2008.1Vol.23 3 2008.1Vol.23 4 5 2008.1Vol.23 2008.1Vol.23 6 7 2008.1Vol.23 2008.1Vol.23 8 9 2008.1Vol.23 10 2008.1Vol.23 11 2008.1Vol.23 12 2008.1Vol.23 Center 13 2008.1Vol.23
日本糖尿病学会誌第58巻第7号
l l l l β μ l l l l l l α l l l l l l l μ l l l α l l l l l μ l l l l l l l l l l l l l μ l l l l l β l μ l μ l μ l μ l l l l l μ l l l μ l l μ l l l α α l μ l l μ l α l μ l α l l l μ l l l μ l l μ l
Vol.171 2004.9.15 14 100 5 10 15 52 53 55 1 7 55 58 63 3 26 53 3 6 9 2 3 6 9 6 52 53 55 3 9 5 1 7 10 14 4 12 8 11
Vol.170 2004.9.9 9 17 9 17 1000 8 10 9 17 14:00 17:00 30 28 Vol.171 2004.9.15 14 100 5 10 15 52 53 55 1 7 55 58 63 3 26 53 3 6 9 2 3 6 9 6 52 53 55 3 9 5 1 7 10 14 4 12 8 11 9.17 10 15 38 51 53 55 6 2
受賞講演要旨2012cs3
アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート α β α α α α α
CRA3689A
AVIC-DRZ90 AVIC-DRZ80 2 3 4 5 66 7 88 9 10 10 10 11 12 13 14 15 1 1 0 OPEN ANGLE REMOTE WIDE SET UP AVIC-DRZ90 SOURCE OFF AV CONTROL MIC 2 16 17 1 2 0 0 1 AVIC-DRZ90 2 3 4 OPEN ANGLE REMOTE SOURCE OFF
204 / CHEMISTRY & CHEMICAL INDUSTRY Vol.69-1 January 2016 047
9 π 046 Vol.69-1 January 2016 204 / CHEMISTRY & CHEMICAL INDUSTRY Vol.69-1 January 2016 047 β γ α / α / 048 Vol.69-1 January 2016 π π π / CHEMISTRY & CHEMICAL INDUSTRY Vol.69-1 January 2016 049 β 050 Vol.69-1
P.3 P.4 P.9 P.11
MOST is the best! P.3 P.4 P.9 P.11 P. P.6 P.7 P.8 P.19 P.14 1 2 P.14 1 2 12,036 P.14 4 13,40 P.14 3 P.12P.14 P.12P.14 6 P.12 P.1 7 P.1 7 P.1 8 P.1 9 P.16 11 P.12 P.1 P.1 P.16 12 P.16 13 P.16-13 P.12 P.16
1) van Meer, G., Op den Kamp, J. A.: J. Cell. Biochem., 19, 193-2040982) 2) Gaffet, P., Bettache, N., Bienvenue, A.: Biochemistry, 34, 6762-6769(1995) 3) Sims, P. J., Wiedmer, T.: Thromb. Haemost., 86,
33...\1
THE ASSOCIATION FOR REAL ESTATE SECURITIZATION 33 2008May-June 3 15 21 29 37 48 2 ARES SPECIAL ARES May-June 2008 3 ARES SPECIAL 4 ARES May-June 2008 ARES SPECIAL ARES May-June 2008 5 6 ARES May-June 2008
日本分子第4巻2号_10ポスター発表.indd
JSMI Report 62 63 JSMI Report γ JSMI Report 64 β α 65 JSMI Report JSMI Report 66 67 JSMI Report JSMI Report 68 69 JSMI Report JSMI Report 70 71 JSMI Report JSMI Report 72 73 JSMI Report JSMI Report 74
yakugaku-kot.ppt
2009 Masaaki Kotera kot@kuicr.kyoto-u.ac.jp 2 I II / A () B1 () B2 B12 C () D A D () () () () DNA 5- http://www.genome.jp/kegg/pathway.html KEGG PATHWAY Database Xenobiotics biodegradation http://www.genome.jp/kegg/pathway.html
12„”‡Pfiú“ƒ-PDFŠp
5 Q Q Q Q ggg g f bbb -b b g b g g g a b f g r t y - 7 g bb f 6 E D f f f 2 2 2 2 2 f g f 2 f 2 f 2 g a g a b f a f g a a a - a f b a f b b b b bb bb E E E R Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q
B
B YES NO 5 7 6 1 4 3 2 BB BB BB AA AA BB 510J B B A 510J B A A A A A A 510J B A 510J B A A A A A 510J M = σ Z Z = M σ AAA π T T = a ZP ZP = a AAA π B M + M 2 +T 2 M T Me = = 1 + 1 + 2 2 M σ Te = M 2 +T
drug development Toshimi Michigami, E-mail : michigami@mch.pref.osaka.jp Keiichi Ozono, E-mail : keioz@ped.med.osaka-u.ac.jp The progress in the research on vitamin D 1) McCollum, E. V. et al.:
/‚“1/ŒxŒ{‚×›î’æ’¶
60 1 pp.3-8 2010 1. H1N1 1) 2) 3) 4) ERATO 2009 H1N1 21 H1N1 HA PB2 2009 3 Pandemic H1N1 2009 WHO 6 11 21 2009 11 2010 4 21 H1N1 H1N1 2009 4 15 CDC 108-8639 4-6-1 TEL: 03-5449-5281 FAX: 03-5449-5408 E-mail:
能書単頁9[1].5(2)
![能書単頁9[1].5(2)](/thumbs/87/96620151.jpg "能書単頁9[1].5(2)")
ips CytoTune -ips ver.1.0 1 I CytoTune ips 3 II 3 3 4 5 III CytoTune ips ips 6 6 6 6 7 1) 2) ips 8 ips 8 SeV 9 SeV 10 IV Q&A 11 V 12 12 VI...13 13...13 2 I CytoTune ips CytoTune ips 4 OCT3/4SOX2 KLF4c
VOL33NO.3/2010 A B A B p-erk1/2 Time (min) 0 1 2 5 10 15 30 60 90 120 Erk1/2 Time (min) 0 1 2 5 10 15 30 60 90 120 p-vasp VASP C D enos/gapdh x-fold vs sham 2.0 1.5 1.0 0.5 * 0 ANP (-) (+) (-)
180126_TOO_ウイルス感染症研究者向け資料【最終】.indd
ウイルス 感染症研究 実験特集 不可能を可能にする NanoLuc テクノロジー NanoLuc テクノロジーをご利用のウイルス 感染症研究に携わるユーザー 4 名の方に最新の 研究成果についてご寄稿頂きました プロメガが開発した NanoLuc は 19 KDa の低分子の発光酵素であり 従来のホタルルシフェラーゼの 1/3 の分子量であるにもかかわらず 発 光レベルは 1 倍にも達します この
381
P381 P386 P396 P397 P401 P423 P430 P433 P435 P437 P448 P451 P452 381 382 383 384 385 3.0mm 5.0mm 3.0mm 5.0mm SK SK3.0mm SK5.0mm 3.0mm PUR PUR3.0mm 2.0mm 2.0mm3.0mm 2.5mm 2.5mm3.0mm 3.0mm 5.0mm 3.0mm 1.8mm
untitled
RYZA IL & FAT CHEMICAL C., LTD. SAKURA EXTRACT Ver.1.4MK Ver. 1.4MK 1) 1300 1929 1 Ver. 1.4MK Sakura 1-caffeoyl---D-glucopyranoside quercetin 3---D-glucopyranoside 1) :, 4, 11-22 (1995). 2 Ver. 1.4MK 3
プラズマ・核融合学会
1. Philosophy of Radiological Protection and Radiation Hazard Protection Law 1) Oita University of Nursing and Health Sciences, Oita, OITA 870-1201, Japan 2) National Institute for Fusion Science, Toki,
001-007 扉・口絵・目次
1 6 6 7 1 a a a a 2 a a a 3 4 5 a 6 7 8 9 10 a 11 a a a 12 13 14 15 a 16 17 18 19 20 21 22 23 24 b b 25 b 26 27 aa 28 r r 29 a s d f 30 b b 31 32 33 1 34 35 36 37 38 6 39 6 40 41 42 43 44 45 7 47 48
MI( MI() 100% 100% 75% 75% 33% 75% 60% 40% 25% 60% 1 2 3 4 5 6 7 8 9 () 12 () () () !! 1. 2. 3. 1. 2. () () () 3-5% ex. ex. 11 ex. () ex. ex. : ex. : (insula) () () ( 2009 ) () ( ) YES! ()
2
1 2 3 4 5 6 ( ) 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 6+ 6-5 2 6-5- 6-5+ 5-5- 5- 22 6+ 6-6+ 6-6- S-P time 10 5 2 23 S-P time 5 2 5 2 ( ) 5 2 24 25 26 1 27 28 29 30 95 31 ( 8 2 ) http://www.kishou.go.jp/know/shindo/kaisetsu.html
ボールねじ
A A 506J A15-6 A15-8 A15-8 A15-11 A15-11 A15-14 A15-19 A15-20 A15-24 A15-24 A15-26 A15-27 A15-28 A15-30 A15-32 A15-35 A15-35 A15-38 A15-38 A15-39 A15-40 A15-43 A15-43 A15-47 A15-47 A15-47 A15-47 A15-49
2007 Vol.56 No.6 総説 丸山浩樹
Reprinted from RADIOISOTOPES, Vol.56,.6 June 2007 Japan Radioisotope Association http : //www.jrias.or.jp/ α β α β ε m z α µ µ α m z m z µ µ Curr. Opin. Biotechnol J. Proteome Res Rapid Commun. Mass
第85 回日本感染症学会総会学術集会後抄録（III）
β β α α α µ µ µ µ α α α α γ αβ α γ α α γ α γ µ µ β β β β β β β β β µ β α µ µ µ β β µ µ µ µ µ µ γ γ γ γ γ γ µ α β γ β β µ µ µ µ µ β β µ β β µ α β β µ µµ β µ µ µ µ µ µ λ µ µ β µ µ µ µ µ µ µ µ
he T N/ N/
6.000 1.000 0.800 0.000 0.500 1.500 3.000 1.200 0.000 0.000 0.000 0.000 0.000-0.100 he 1.500 T 0.100 1.50 0.00 2 24.5 N/ 3 18.0 N/ 3 28.0 18.7 18.7 14.0 14.0 X() 20.000 Y() 0.000 (kn/2) 10.000 0.000 kn
Sulfonylurea Receptors Pancreatic Type: SUR1 Cardiac Type: SUR2A Smooth Muscle Type: SUR2B Kir Channels uka-rp-1/kir6.1 BIR/Kir6.2 1) Ho K, et al : Cloning and expression of an inwardly rectifying ATP-regulated
Review Fumio Imamoto1, Takefumi Sone1, Kazuhide Yahata1, Yukari Sasaki1, Masatoshi Takagi2, Kazuhiro Maeshima2, Naoko 25) Dong, W. K. et al.: Gene, 91, 217-223 (1990) 26) Masatsugu, T. et al.:
untitled
ORYZA POLYAMINE ORYZA POLYAMINE -P -PC -LC 1. Ver.1.0 MM ver. 1.0MM 1) Roseeuw D.I. et al., Epidermal keratinocytes actively maintain their intracellular polyamine levels. Cell Tissue Kinet. 16, 493-504
第88回日本感染症学会学術講演会後抄録（III）
!!!! β! !!μ μ!!μ μ!!μ! !!!! α!!! γδ Φ Φ Φ Φ! Φ Φ Φ Φ Φ! α!! ! α β α α β α α α α α α α α β α α β! β β μ!!!! !!μ !μ!μ!!μ!!!!! !!!!!!!!!! !!!!!!μ! !!μ!!!μ!!!!!! γ γ γ γ γ γ! !!!!!! β!!!! β !!!!!! β! !!!!μ!!!!!!
(1) 2000 ( ) ( ) 1000 2000 1000 0 http://www.spacepark.city.koriyama.fukushima.jp/ http://www.miraikan.jst.go.jp/ http://www.nasda.go.jp/ 3000 1 1 http://www.city.nara.nara.jp/citizen/jyugsidu/jgy/jsj/
36 th IChO : - 3 ( ) , G O O D L U C K final 1
36 th ICh - - 5 - - : - 3 ( ) - 169 - -, - - - - - - - G D L U C K final 1 1 1.01 2 e 4.00 3 Li 6.94 4 Be 9.01 5 B 10.81 6 C 12.01 7 N 14.01 8 16.00 9 F 19.00 10 Ne 20.18 11 Na 22.99 12 Mg 24.31 Periodic
取扱説明書[d-01G]
![取扱説明書[d-01G]](/thumbs/40/20690255.jpg "取扱説明書[d-01G]")
d-01g 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 T 18 1 2 19 3 1 2 4 3 4 20 21 1 2 3 4 22 1 T 2 T 1 T 2 T 23 1 T 1 2 24 25 1 2 26 1 T 27 1 2 3 1 2 3 28 29 30 1 2 1 2 31 1 2 3 32 1 2 3 4 5 1 2 3 4 33 1
untitled
PCR Enzymes & Instruments PCR Stratagene Gradient Cycler Problem PCRDNA Polymerase Solution Stratagene Gradient Cycler PCRQuikChange 3 Stratagene Gradient Cycler 96 96 Fast 384 3 3 0.4 0.1 12 96 Fast 384
P.5 P.6 P.3 P.4 P.7 P.8 P.9 P.11 P.19
MOST is the best! P.5 P.6 P.3 P.4 P.7 P.8 P.9 P.11 P.19 P.14 1 2 P.14 1 2 12,036 17,025 P.14 3 P.14 4 NEW P.12P.14 5 P.12P.14 6 P.12 P.15 7 NEW P.15 8 P.15 9 P.15 7 P.15 10 P.15 10 NEW P.12 P.15 11 P.15
Database Center for Life Science Online Service
Database Center for Life Science Online Service Database Center for Life Science Online Service Database Center for Life Science Online Service Database Center for Life Science Online Service SMN (Survival